Use of angiotensin receptor antagonists in patients with ACE inhibitor induced angioedema

Pharmacy World and Science

Volumn 26, Issue 4, 2004, Pages 191-192

  Fuchs, Sabine A ^a   Meyboom, Ronald H B ^b   Van Puijenbroek, Eugène P ^c   Guchelaar, Henk Jan ^d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UPPSALA MONITORING CENTRE   (Sweden)

^c 'S Hertogenbosch   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ACE inhibitors; Adverse effect; Angioedema

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANGIONEUROTIC EDEMA; CLINICAL TRIAL; COUGHING; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; FACE EDEMA; HEART FAILURE; HUMAN; LARYNX EDEMA; NOTE; ORBIT DISEASE; RELAPSE; SIDE EFFECT; TONGUE DISEASE;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANGIONEUROTIC EDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENZIMIDAZOLES; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; NETHERLANDS; RANDOMIZED CONTROLLED TRIALS; RECEPTORS, ANGIOTENSIN; TETRAZOLES; TIME FACTORS; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 4043104220     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAR.0000035902.67235.5c     Document Type: Note

References (13)

1. Granger CB, McMurray JJV, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzym inhibitors: the CHARM-Alternative trial. Lancet 2003; 362: 772-6.
2. van Rijnsoever EW, Kwee-Zuiderwijk WJM, Feenstra J. Angioneurotic edema attributed to the use of losdartan. Arch Intern Med 1998; 158: 2063-5.
3. Griendling KK, Lassegue B, Alexander RW. Angiotensin receptors and their therapeutic implications. Annu Rev Pharmacol Toxicol 1996; 36: 281-306.
4. Liu YH, Yang XP, Sharov VG, Nass O, Sabbah HN, Peterson E, Carratero UA. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure: role of kinins and angiotensin II type 2 receptors. J Clin Invest 1997; 99: 1926-35.
5. Gohlke P, Pees C, Unger T. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension 1998; 31: 349-55.
6. Vleerning W, Stricker C, de Wildt DJ, van Amsterdam JG. ACE inhibitor-induced angioedema. Incidence, prevention and management. Drug Saf 1998; 18: 171-88.
7. Warner KK, Visconti JA, Tschampel MM. Angiotensin II receptor blockers in patients with ACE inhibitor induced angioedema. Ann Pharmacother 2000; 34: 526-8.
8. Howes LG, Tran D. Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor-induced angioedema? Drug Saf 2002; 25: 73-6.
9. Fuchs SA, Koopmans RP, Guchelaar HJ, Brodie-Meijer CC, Meyboom RH. Are angiotensin II receptor antagonists safe in patients with previous angiotensin-converting enzyme inhibitor-induced angioedema? Hypertension 2001; 37: E1.
10. Abdi R, Dong VM, Lee CJ, Ntuso KA. Angiotensin II receptor blocker-associated angioedema: on the heels of ACE inhibitor angioedema. Pharmacotherapy 2002; 22: 1173-5.
11. Touraud JP, Collet E, Louguet C, Sgro C, Dalac S, Dutronc Y, Lambert D. Cross-sensitivity between angiotensin-converting enzyme inhibitor and angiotensin II receptor antagonist. Ann Dermatol Venereol 2002; 129: 1033-6.
12. de Paz S, Martin AB, Iglesias A, Dominguez AR. Angioedema-urticaria caused by angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists. Med Clin 1999; 113: 759.
13. Lo KS. Angioedema associated with candesartan. Pharmacotherapy 2002; 22: 1176-9.